Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
Clinical trial NCT03611010 · COMPLETED
Trial details
- NCT number
- NCT03611010
- Sponsor
- Cumberland Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-07
- Primary completion
- 2020-02-17
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.